Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2021)
✉ Email this page to a colleague
SUPERNUS PHARMACEUTICALS, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-09-17 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-01-06 |
| Cause | 35:271 Patent Infringement | Assigned To | Georgette Castner |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 10,314,790; 8,298,576; 8,298,580; 8,663,683; 8,877,248; 8,889,191; 8,992,989; 9,549,940; 9,555,004; 9,622,983 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. ZYDUS PHARMACEUTICALS (USA) INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SUPERNUS PHARMACEUTICALS, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-09-17 | 1 | Complaint | 940 patent”), 9,555,004 (“the ’004 patent”), 9,622,983 (“the ’983 patent”), and 10,314,790 (“the ’790…PageID: 2 ’576 patent”), 8,298,580 (“the ’580 patent”), 8,663,683 (“the ’683 patent”), 8,877,248 (“the…“the ’248 patent”), 8,889,191 (“the ’191 patent”), 8,992,989 (“the ’989 patent”), 9,549,940 (“the ’940… This is a civil action for patent infringement arising under the patent laws of the United States, …790 patent”) attached hereto as Exhibits A–J (collectively, “the patents in suit”). | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
